Rees K, Bennett P, West R, Davey Smith G, Ebrahim S
Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol, UK, BS8 2PR.
Cochrane Database Syst Rev. 2004(2):CD002902. doi: 10.1002/14651858.CD002902.pub2.
Psychological interventions can form part of comprehensive cardiac rehabilitation programmes (CCR). These interventions may include stress management interventions, which aim to reduce stress, either as an end in itself or to reduce risk for further cardiac events in patients with heart disease.
To determine the effectiveness of psychological interventions, in particular stress management interventions, on mortality and morbidity, psychological measures, quality of life, and modifiable cardiac risk factors, in patients with coronary heart disease (CHD).
We searched CCTR to December 2001 (Issue 4, 2001), MEDLINE 1999 to December 2001 and EMBASE 1998 to the end of 2001, PsychINFO and CINAHL to December 2001. In addition, searches of reference lists of papers were made and expert advice was sought.
RCTs of non-pharmacological psychological interventions, administered by trained staff, either single modality interventions or a part of CCR with minimum follow up of 6 months. Adults of all ages with CHD (prior myocardial infarction, coronary artery bypass graft or percutaneous transluminal coronary angioplasty, angina pectoris or coronary artery disease defined by angiography). Stress management (SM) trials were identified and reported in combination with other psychological interventions and separately.
Studies were selected, and data were abstracted, independently by two reviewers. Authors were contacted where possible to obtain missing information.
Thirty six trials with 12,841 patients were included. Of these, 18 (5242 patients) were SM trials. Quality of many trials was poor with the majority not reporting adequate concealment of allocation, and only 6 blinded outcome assessors. Combining the results of all trials showed no strong evidence of effect on total or cardiac mortality, or revascularisation. There was a reduction in the number of non-fatal reinfarctions in the intervention group (OR 0.78 (0.67, 0.90), but the two largest trials (with 4809 patients randomized) were null for this outcome, and there was statistical evidence of publication bias. Similar results were seen for the SM subgroup of trials. Provision of any psychological intervention or SM intervention caused small reductions in anxiety and depression. Few trials reported modifiable cardiac risk factors or quality of life.
REVIEWERS' CONCLUSIONS: Overall psychological interventions showed no evidence of effect on total or cardiac mortality, but did show small reductions in anxiety and depression in patients with CHD. Similar results were seen for SM interventions when considered separately. However, the poor quality of trials, considerable heterogeneity observed between trials and evidence of significant publication bias make the pooled finding of a reduction in non-fatal myocardial infarction insecure.
心理干预可成为综合心脏康复计划(CCR)的一部分。这些干预可能包括压力管理干预,其目的是减轻压力,要么作为其本身的目标,要么是为了降低心脏病患者发生进一步心脏事件的风险。
确定心理干预,尤其是压力管理干预,对冠心病(CHD)患者的死亡率、发病率、心理指标、生活质量和可改变的心脏危险因素的有效性。
我们检索了截至2001年12月(2001年第4期)的CCTR、1999年至2001年12月的MEDLINE以及1998年至2001年底的EMBASE、截至2001年12月的PsychINFO和CINAHL。此外,还检索了论文的参考文献列表并征求了专家意见。
由经过培训的人员实施的非药物心理干预的随机对照试验,无论是单一模式干预还是CCR的一部分,最少随访6个月。所有年龄段患有CHD的成年人(既往心肌梗死、冠状动脉搭桥术或经皮腔内冠状动脉成形术、心绞痛或血管造影定义的冠状动脉疾病)。确定并分别报告了压力管理(SM)试验以及与其他心理干预相结合的试验。
由两名 reviewers 独立选择研究并提取数据。尽可能联系作者以获取缺失信息。
纳入了36项试验,共12,841名患者。其中,18项(5242名患者)为SM试验。许多试验质量较差,大多数未报告分配方案的充分隐藏情况,只有6名盲法结局评估者。综合所有试验结果显示,没有强有力的证据表明对总死亡率或心脏死亡率或血管重建有影响。干预组非致命性再梗死的数量有所减少(比值比0.78(0.67, 0.90)),但两项最大规模的试验(随机分组4809名患者)在此结局上为阴性,且有出版偏倚的统计学证据。SM试验亚组也有类似结果。提供任何心理干预或SM干预都会使焦虑和抑郁略有减轻。很少有试验报告可改变的心脏危险因素或生活质量。
reviewers的结论:总体而言,心理干预没有证据表明对总死亡率或心脏死亡率有影响,但确实表明CHD患者的焦虑和抑郁略有减轻。单独考虑SM干预时也有类似结果。然而,试验质量差、试验间观察到的显著异质性以及显著出版偏倚的证据使得关于非致命性心肌梗死减少的汇总发现不可靠。